According to the Financial Associated Press (Shanghai, editor Shi Zhengcheng), as of 23:42 on November 4, Beijing time, the number of confirmed cases of new coronary pneumonia worldwide rose to 248,282,374, of which the number of deaths was adjusted to 5,025,636.
As of press time, France (7282876 cases), Italy (4782802 cases), the United Kingdom (9215832 cases), Germany (4676499 cases) and other European countries and the United States (46254383 cases) have maintained the increase in confirmed cases at a recent level, and will face the holiday season again in the future. And relax the test of immigration policy. At the same time, the epidemic situation in Central European countries such as Poland and the Czech Republic is increasing rapidly.
(Overview of the global epidemic, source: Johns Hopkins University) Similar to Europe and the United States, with the exception of Russia (8533706 cases), most countries in Southeast Asia are still in the decline after the last round of the epidemic, but include India, the Philippines, and Malaysia , Thailand, Vietnam, Mongolia and other countries still have thousands of new cases every day, and some countries also have the risk of insufficient detection capabilities to show the complete epidemic situation.
The following is the growth curve of daily confirmed cases in relevant countries:
(Source: Finance Association, Wind) Global epidemic situation
[National Health Commission: 87+16 cases of local infections were newly added yesterday]
From 0-24:00 on November 3, 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps reported 104 new confirmed cases. Among them, there were 17 imported cases, including 1 case from asymptomatic infection to confirmed case. There are 87 local cases (45 in Heilongjiang, 44 in Heihe, 1 in Harbin; 23 in Hebei, including 20 in Shijiazhuang and 3 in Xinji; 4 in Ningxia, all in Yinchuan; 3 in Jiangsu, all in Changzhou City; 3 cases in Henan, including 2 cases in Zhengzhou City and 1 case in Zhoukou City; 2 cases in Inner Mongolia, both in Alxa League; 2 cases in Sichuan, both in Chengdu; 2 cases in Gansu, including 1 in Lanzhou City and 1 in Tianshui City Cases; 1 case in Shandong, in Rizhao City; 1 case in Chongqing, in Shapingba District; 1 case in Qinghai, in Xining City), including 2 cases from asymptomatic infections to confirmed cases (1 case in Shandong, 1 case in Sichuan).
[Hong Kong Special Administrative Region Government: Strive to gradually and orderly resume and “clearance” in the Mainland as soon as possible]
According to a media report on November 4, a spokesperson for the Hong Kong Special Administrative Region Government said on the 4th that it will continue to “clear” as the goal, further strengthen epidemic prevention and anti-epidemic measures, create favorable conditions, and strive to gradually and orderly resume and “customs clearance” in the Mainland as soon as possible. Effectively respond to the expectations of the general public.
The Hong Kong Special Administrative Region Government and experts from relevant Mainland departments held a video exchange meeting on November 2 to further discuss and explain the feedback and information submitted by the Special Administrative Region Government to the Mainland after the first meeting between the two places on September 26. Improve mutual understanding. The video communication was constructive and was moving towards the purpose of “customs clearance”, and it played a positive role in promoting the holding of the second meeting between the two places as soon as possible.
[U.S. Issues Vaccination Orders to Large and Medium-sized Enterprises]
On Thursday, local time, the U.S. Department of Labor’s Department of Safety and Health promulgated the new crown vaccination rules, which clearly require companies with 100 or more employees in the United States to provide employees with vaccination holidays and ensure that people who have not been vaccinated wear masks. At the same time, employees of these companies also need to complete the vaccination before January 4 next year, or commit to weekly virus testing.
[WHO raises concerns about the epidemic in Europe and Central Asia]
The WHO said on Thursday that the recent surge in confirmed cases in Europe and Central Asia has also made these areas the epicenter of the epidemic again. According to the WHO, the new crown deaths reported in these two regions last week accounted for almost half of the global deaths.
[Moderna downgrades new crown vaccine sales guidelines]
Biopharmaceutical company Moderna announced on Thursday that it will adjust the company’s 2021 new crown vaccine sales guidance to 15-18 billion U.S. dollars, compared with the company’s previous forecast of 20 billion U.S. dollars.
[Mersk’s new crown oral drug was approved for marketing in the UK]
The British Medicines and Medical Products Regulatory Agency announced on Thursday that Merck’s Molnupiravir (Molnupiravir), which is used to treat new crown virus infections, has been approved for marketing in the country. This is also the world‘s first regulatory approval for the drug.
Market performance
After the Fed’s monetary policy changes have settled steadily, the market’s focus has returned to corporate earnings and Friday’s non-agricultural data. The overall trend of technology stocks that are more sensitive to interest rate hikes is stronger than the broader market. As the Bank of England did not raise interest rates as expected, the European market also moved higher under the positive support of the “continuation of easing”.
(Thursday European and American stock market trends, source: Investing)